Pricing Log in Create free account

Atea Pharmaceuticals, Inc. (AVIR) vs Editas Medicine, Inc. (EDIT)

Atea Pharmaceuticals, Inc. and Editas Medicine, Inc. are both Biotechnology companies. Atea Pharmaceuticals, Inc. and Editas Medicine, Inc. are of similar size ($374.7M and $363.3M). Atea Pharmaceuticals, Inc. has the higher net margin (0.00% vs −157.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Atea Pharmaceuticals, Inc. leads on 8 and Editas Medicine, Inc. on 6.

Valuation

Metric AVIR EDIT Biotechnology median
P/E n/m n/m 8.50
P/S 0.98 5.96 9.71
P/B 1.69 2.66 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.36 2.15 9.21
Earnings yield (48.15%) (31.91%) (33.15%)
Free cash flow yield (159.02%) (42.90%) (25.50%)

Profitability

Metric AVIR EDIT Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (161.39%) 0.00%
Net margin 0.00% (157.32%) 0.00%
Free cash flow margin 0.00% (255.88%) 0.00%
Return on equity (58.14%) (118.82%) (56.36%)
Return on assets (52.99%) (33.02%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AVIR EDIT Biotechnology median
Revenue growth (TTM) — 20.83% 6.02%
EPS growth (last fiscal year) 3.00% 37.50% 30.26%
Revenue growth, 5-year CAGR — (14.89%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AVIR EDIT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.13 3.19 4.72
Net debt to EBITDA 1.63 0.94 0.96

Dividend

Metric AVIR EDIT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AVIR EDIT Biotechnology median
Market cap 363.33m 374.74m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack